Table 1.
Country | Prevaccination |
Postvaccination |
Difference in Prevalence, % (aOR [95% CI]) | P Value | ||||
---|---|---|---|---|---|---|---|---|
Sample, No. | Carriage, No. | Prevalence, % | Sample, No. | Carriage, No. | Prevalence, % | |||
Burkina Faso | 20 326 | 80 | 0.39 | 22 093 | 0 | 0 | NA | .003 |
Chad | 998a | 6 | 0.6 | 5001b | 1 | 0.02 | 98 (0.019 [.002–.138]) | |
4278c | 32 | 0.7 |
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; NA, not applicable.
a First survey conducted September–November 2010 (13–15 months before vaccination).
b Third survey, conducted April–June 2012 (4–6 months after vaccination).
c Second survey, conducted August–October 2011 (2–4 months before vaccination).